Save
Three-minute thesis
ESGO eAcademy, Faculty / Presenters, 313681
Role of immunotherapy in gynaecological malignancies
ESGO eAcademy, Antonio Gonzalez-Martin, 312516
The ABRAX trial and what next?
ESGO eAcademy, David Cibula, 312515
8:00 - 10:00 CET - Major advances in gynaecological cancers 2020 - Part II
ESGO eAcademy, Faculty / Presenters, 313071
10:20- 11:45 CET - NEW Endometrial cancer guidelines & Endometrial cancer surgery
ESGO eAcademy, Faculty / Presenters, 313072
Endometrial cancer adjuvant therapy
ESGO eAcademy, Faculty / Presenters, 313073
Endometrial cancer (stage 4 & metastatic), Controversies & Closing remarks
ESGO eAcademy, Faculty / Presenters, 313074
Industry symposium - sponsored by Intuitive Surgical: Honoring the past 10 years of robotic-assisted surgery and paving the way for the next decade
ESGO eAcademy, Faculty / Presenters, 313583
Industry symposium: Honoring the past 10 years of robotic-assisted surgery and paving the way for the next decade
ESGO eAcademy, Faculty / Presenters, 313083
Industry symposium: Current State of the Art in the Management of Endometrial Cancer
ESGO eAcademy, Faculty / Presenters, 313084
NIRAPARIB in patients with newly diagnosed advanced ovarian BRCAM cancer: A post hoc analysis of the PRIMA/ENGOT-OV26/GOG-3012 trial
ESGO eAcademy, Jacob Korach, 312514
Significant variation in treatment and survival outcomes in stage 2-4 ovarian cancer in England: results from the national ovarian cancer feasibility audit pilot
ESGO eAcademy, Sudha Sundar, 312513
Increased institutional surgical experience in robot-assisted radical hysterectomy for early stage cervical cancer reduces recurrence rate. Results from a nationwide study.
ESGO eAcademy, Linnea Ekdahl, 313494
A randomised phase II study of NINTEDANIB (BIBF1120) compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium. (NICCC/ENGOT-OV36)
ESGO eAcademy, Rosalind Glasspool, 312512
Attitudes towards risk reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: A COHORT study
ESGO eAcademy, Faiza Gaba, 312813
Early salpingectomy (tubectomy) with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy to improve quality of life in women with a BRCA1/2 pathogenic variant (TUBA study): A prospective multicenter preference trial
ESGO eAcademy, Miranda P. Steenbeek, 312812
Impact of the covid pandemic on gynaecological cancer surgery – results from the covidsurg gynaecological cancer international study
ESGO eAcademy, Sudha Sundar, 312511
Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/engot-ov26/gog-3012 study
ESGO eAcademy, Elena Ioana Braicu, 312510
Succor cone: is it cervical conization a protective maneuver
ESGO eAcademy, ENRIQUE CHACON, 312509
Industry symposium: A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 313081
Industry symposium - sponsored by Clinical Care Options: A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer
ESGO eAcademy, Faculty / Presenters, 313585
Ovarian relapse; platinum not an option. State of the art lecture
ESGO eAcademy, Ignace Vergote, 312508
Ovarian relapse; platinum not an option. Set up the case
ESGO eAcademy, Jalid Sehouli, 312507
Ovarian first-line & Ovarian relapse; platinum an option
ESGO eAcademy, Faculty / Presenters, 313068
Ovarian relapse; platinum an option. State of the art lecture
ESGO eAcademy, Jonathan Ledermann, 312506
Ovarian relapse; platinum an option. Set up the case
ESGO eAcademy, Isabelle Ray-Coquard, 312505
Integrating PARPi in front line of advanced ovarian cancer
ESGO eAcademy, Antonio Gonzalez-Martin, 313693
State of the art lecture 1st line Ovarian Cancer Treatment
ESGO eAcademy, Eric Pujade-Lauraine, 312504
Ovarian first-line. Set up the case
ESGO eAcademy, Philipp Harter, 312503
Ovarian cancer surgery. Panel Discussion
ESGO eAcademy, Faculty / Presenters, 313657
Ovarian cancer surgery. State of the art lecture
ESGO eAcademy, Andreas du Bois, 312502
Ovarian cancer surgery. Set up the case
ESGO eAcademy, Luis Chiva, 312501
ESGO-ESMO ovarian cancer guidelines
ESGO eAcademy, Nicoletta Colombo, 312500
Industry symposium: Role of Tumor Treatment Fields (TTFields) in the Management of Platinum-Resistant Ovarian Cancer (PROC)
ESGO eAcademy, Faculty / Presenters, 313080
Presidential session & Introduction to next day programme
ESGO eAcademy, Faculty / Presenters, 313070
8:00 - 9:15 CET - Ovarian cancer guidelines & Ovarian cancer surgery
ESGO eAcademy, Faculty / Presenters, 313067
Ovarian relapse; platinum not an option
ESGO eAcademy, Faculty / Presenters, 313069
Industry symposium - sponsored by Novocure: Role of Tumor Treatment Fields (TTFields) in the Management of Platinum-Resistant Ovarian Cancer (PROC)
ESGO eAcademy, Faculty / Presenters, 313582
Expanding maintenance options for patients with advanced ovarian cancer
ESGO eAcademy, Faculty / Presenters, 313082
Industry symposium - sponsored by GSK: Expanding maintenance options for patients with advanced ovarian cancer
ESGO eAcademy, Faculty / Presenters, 313586
Zejula niraparib - Video
ESGO eAcademy, Faculty / Presenters, 313578
Online registration - Purchase Access to conference
ESGO eAcademy, ESGO, 312313
Conference Programme
ESGO eAcademy, Faculty / Presenters, 313571
Elekta - Video
ESGO eAcademy, Faculty / Presenters, 312868
Importance of translational research and bio-banking for personalized treatment
ESGO eAcademy, Elena Ioana Braicu, 312499
ENGOT: Improving patients´ outcome through clinical trials. Decade of achievements
ESGO eAcademy, Mansoor Raza Mirza, 312498
ESGO SoA GSK Oncology Pipeline Materials
ESGO eAcademy, Faculty / Presenters, 313577
ENGOT collaboration
ESGO eAcademy, Antonio Gonzalez-Martin, 312497
UK Prescribing Information
ESGO eAcademy, Faculty / Presenters, 313576
Welcome from ESGO president and ESGO SoA 2020 chairs
ESGO eAcademy, Faculty / Presenters, 313653
Small Access, Great Effect - The Intrauterine BIGATTI Shaver (IBS®) in 6 mm
ESGO eAcademy, Faculty / Presenters, 313523
Essential in Gynecological Laparoscopy - Uterine manipulators from KARL STORZ
ESGO eAcademy, Faculty / Presenters, 313522
ESGO 2020 PLATFORM USER GUIDE
ESGO eAcademy, Faculty / Presenters, 313618
Cervical cancer - Metastatic and relapsed disease. State of the art lecture
ESGO eAcademy, Ana Oaknin, 312494
12:00 - 13:00 CET Cervical cancer: Metastatic and relapsed disease
ESGO eAcademy, Faculty / Presenters, 313496
Cervical cancer - Metastatic and relapsed disease - set up a case
ESGO eAcademy, Nicole Concin, 312493
Update on Cervical cancer chemoradiation
ESGO eAcademy, Jacob Lindegaard, 312492
Update on Cervical cancer surgery
ESGO eAcademy, David Cibula, 312491
Welcome Message
ESGO eAcademy, Faculty / Presenters, 313549
Medtronic - Video
ESGO eAcademy, Faculty / Presenters, 313546
Uterine Tissue Removal with TruClear™
ESGO eAcademy, Faculty / Presenters, 313545
LigaSure™ Retractable L-Hook Laparoscopic Sealer/Divider- One device. Five function
ESGO eAcademy, Faculty / Presenters, 313544
Veriset™. Bleeding will stop. That´s a fact.
ESGO eAcademy, Faculty / Presenters, 313543
Learn about HRD testing - digital poster
ESGO eAcademy, Faculty / Presenters, 313487
See the new ovarian cancer indication
ESGO eAcademy, Faculty / Presenters, 313486
V-loc™ Wound Closure Device
ESGO eAcademy, Faculty / Presenters, 313542
Learn about HRD testing - digital brochure
ESGO eAcademy, Faculty / Presenters, 313541
Explore the LYNPARZA data
ESGO eAcademy, Faculty / Presenters, 313540
AstraZeneca - Video
ESGO eAcademy, Faculty / Presenters, 313539
10:00 - 11:00 CET - Cervical cancer primary therapy (surgery & chemorad)
ESGO eAcademy, Faculty / Presenters, 313065
Karl Storz - Video
ESGO eAcademy, Faculty / Presenters, 312880
Ambulatory Hysteroscopy – Creating Certainty
ESGO eAcademy, Faculty / Presenters, 312877
IMAGE1 S™ RUBINA™ – mORe to discover
ESGO eAcademy, Faculty / Presenters, 312876
The Standardized Training Concept
ESGO eAcademy, Faculty / Presenters, 312875
The Bipolar 5 mm Office Resectoscope
ESGO eAcademy, Faculty / Presenters, 312874
Geneva - Universal Gynecological Applicator
ESGO eAcademy, Faculty / Presenters, 312871
Venezia™ Advanced Gynecological Applicator Reaching beyond
ESGO eAcademy, Faculty / Presenters, 312870
Flexitron® - Brachytherapy Afterloading Platform
ESGO eAcademy, Faculty / Presenters, 312869
15:35 - 18:35 CET - Welcome and opening, ENGOT: Improving patients´ outcome through clinical trials, Three minute thesis & Introduction to next days programme
ESGO eAcademy, Faculty / Presenters, 313066
11:00 - 12:00 CET - Industry symposium: Precision Medicine in Ovarian Cancer: Understanding the Evolving Role of PARP Inhibitors
ESGO eAcademy, Faculty / Presenters, 313077
13:45 - 14:45 CET - Industry symposium: Advanced Endometrial Cancer: Are We Entering an Age of Immune Checkpoint Inhibitor-based Therapy?
ESGO eAcademy, Faculty / Presenters, 313078
14:45 - 15:15 CET - Company sponsored talk: Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: results from the phase 2 innovaTV 204/GOG-3023/ENGOT-cx6 study
ESGO eAcademy, Faculty / Presenters, 313079
Industry symposium - sponsored by GSK: Advanced Endometrial Cancer: Are We Entering an Age of Immune Checkpoint Inhibitor-based Therapy?
ESGO eAcademy, Faculty / Presenters, 313580
Laparoscopic Repair of External Iliac Vein Injury
ESGO eAcademy, cem yalçınkaya, 313682
Multidisciplinary Management of Liver Metastases in Ovarian Cancer Live Webinar
ESGO eAcademy, Faculty / Presenters, 308554
e-Module Mucinous Tumours
ESGO eAcademy, Faculty / Presenters, 403941
e-Module Mucinous Tumours
ESGO eAcademy, Faculty / Presenters, 313564
Medical treatment and update on recent molecular studies in mucinous ovarian cancer
ESGO eAcademy, Alexandra Leary, 313563
New insights into surgical management of mucinous ovarian cancer
ESGO eAcademy, Philippe Morice, 313562
Restrictions in the histopathological diagnosis of mucinous ovarian carcinoma
ESGO eAcademy, Aikaterini Pavlaki, 313561
16:00 -17:00 CET - Palliative care: mapping the situation in diverse countries
ESGO eAcademy, Faculty / Presenters, 312630
Integrating tumor biology into debulking surgery
ESGO eAcademy, Nicole Concin, 313518
Tumour Board 4: Management of Vulvar cancer patients
ESGO eAcademy, Faculty / Presenters, 313517
Live Session Test
ESGO eAcademy, Faculty / Presenters, 313520
Laparoscopic Extended Pelvic Lymphadenectomy Internal Iliac Vessel System and Sciatic Nerve Anatomy Live Webinar
ESGO eAcademy, Faculty / Presenters, 308553
Technique and Indication for Lymphadenectomy in Ovarian Cancer
ESGO eAcademy, Beyhan Ataseven, 313062
Technique and Role of Laparoscopic Assessment in Gynecologic Oncology
ESGO eAcademy, Fagotti Anna, 313061
Uterus Preserving Therapy in Cervical Cancer
ESGO eAcademy, Nicoletta Colombo, 313060
Risk Factors and Management of Fistula in Gynecological Oncology Surgery: Urinary Tract Fistula
ESGO eAcademy, Christina Fotopoulou, 313059
Risk-adapted Therapy Planning: Upfront Surgery or Chemotherapy First?
ESGO eAcademy, Luis Chiva, 313058

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings